Compare MNOV & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNOV | SNAL |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.5M | 33.2M |
| IPO Year | 2005 | 2022 |
| Metric | MNOV | SNAL |
|---|---|---|
| Price | $1.48 | $0.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 96.1K | 27.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $257,917.00 | ★ $82,330,445.00 |
| Revenue This Year | N/A | $13.87 |
| Revenue Next Year | N/A | $26.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.13 | $0.64 |
| 52 Week High | $2.24 | $3.42 |
| Indicator | MNOV | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 47.97 |
| Support Level | $1.48 | $0.85 |
| Resistance Level | $1.55 | $1.00 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 50.00 | 47.06 |
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.